LOC642361: A Potential Drug Target with Unique Topology (G642361)
LOC642361: A Potential Drug Target with Unique Topology
LOC642361 is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and pancreas. It is a member of the LOC642361 family, which is characterized by the presence of a single transmembrane domain and a unique topology of the transmembrane region.
LOC642361 is involved in a variety of physiological processes in the body, including cell signaling, neurotransmitter signaling, and insulin sensitivity. It is a potential drug target because of its unique structure and the involvement in several disease processes.
One of the most significant functions of LOC642361 is its role in neurotransmitter signaling. LOC642361 is involved in the regulation of neurotransmitter release from axons in the central nervous system, and it is thought to play a role in the development and maintenance of neurotransmitter signaling.
LOC642361 is also involved in the regulation of insulin sensitivity. It has been shown to play a role in the regulation of glucose uptake and storage in tissues, which is important for maintaining insulin sensitivity and preventing the development of type 2 diabetes.
In addition to its involvement in neurotransmitter signaling and insulin sensitivity, LOC642361 is also thought to be involved in cell signaling. It has been shown to play a role in the regulation of cell adhesion, and it is thought to contribute to the development of cancer.
The unique topology of LOC642361 is also of interest. It is a single transmembrane protein that contains a variety of different domains, including an extracellular domain, a transmembrane domain, and an intracellular domain. This unique topology is thought to be important for its function in cell signaling, as it allows the protein to interact with other molecules in the cell membrane in different ways.
LOC642361 is also a potential biomarker for several diseases. For example, it has been shown to be elevated in the blood of individuals with Alzheimer's disease, a progressive neurodegenerative disorder. Additionally, LOC642361 has been shown to be elevated in the urine of individuals with urinary tract cancer, a common form of this disease.
In conclusion, LOC642361 is a protein that is involved in a variety of physiological processes in the body. Its unique topology and the involvement in neurotransmitter signaling, insulin sensitivity, and cell signaling make it a potential drug target. Additionally, its potential as a biomarker for several diseases makes it an important area of research. Further studies are needed to fully understand the role of LOC642361 in these processes and to determine its potential as a drug.
Protein Name: Uncharacterized LOC642361
More Common Targets
LOC642422 | LOC642502 | LOC642590 | LOC642677 | LOC642730 | LOC642846 | LOC642947 | LOC643201 | LOC643339 | LOC643406 | LOC643441 | LOC643454 | LOC643763 | LOC643855 | LOC643923 | LOC644006 | LOC644083 | LOC644086 | LOC644189 | LOC644215 | LOC644277 | LOC644525 | LOC644584 | LOC644634 | LOC644656 | LOC644662 | LOC644669 | LOC644893 | LOC644936 | LOC645086 | LOC645181 | LOC645188 | LOC645266 | LOC645468 | LOC645503 | LOC645967 | LOC646044 | LOC646214 | LOC646358 | LOC646471 | LOC646674 | LOC646736 | LOC646762 | LOC646813 | LOC646836 | LOC646853 | LOC646903 | LOC646934 | LOC646970 | LOC647115 | LOC647132 | LOC647481 | LOC649133 | LOC650157 | LOC650226 | LOC651536 | LOC652276 | LOC652608 | LOC653303 | LOC653503 | LOC653513 | LOC653631 | LOC653653 | LOC653698 | LOC727751 | LOC728024 | LOC728098 | LOC728114 | LOC728138 | LOC728376 | LOC728392 | LOC728417 | LOC728485 | LOC728554 | LOC728660 | LOC728688 | LOC728715 | LOC728739 | LOC728743 | LOC728877 | LOC728989 | LOC729086 | LOC729164 | LOC729173 | LOC729218 | LOC729296 | LOC729444 | LOC729609 | LOC729683 | LOC729732 | LOC729737 | LOC729815 | LOC729870 | LOC729887 | LOC729966 | LOC729973 | LOC730098 | LOC730100 | LOC730101 | LOC730183
